<ѻý>Two T1D Patients Achieve Insulin Independence After Stem Cell Transplantsѻý> These were patients with "really debilitating diabetes," says investigator Jun 27, 2023
<ѻý>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Lossѻý> Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
<ѻý>Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trialѻý> Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
<ѻý>Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerantѻý> More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
<ѻý>Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetesѻý> Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
<ѻý>Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trialѻý> Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
<ѻý>ADA 2022: Racial Residential Segregation, DKA During COVID, and Moreѻý> Noteworthy research presented at the American Diabetes Association annual meeting Jun 08, 2022
<ѻý>Don't Ignore Depression in Youth With Type 1 Diabetesѻý> Depressive symptoms and history of suicide attempts linked with higher HbA1c Jun 08, 2022
<ѻý>DIY Insulin Delivery System Safe, Effective for All Agesѻý> Users spent more time in target glucose range than those on sensor augmented pump therapy Jun 07, 2022
<ѻý>Concerning Trends in Vision Impairment for Adults With Diabetes?ѻý> Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
<ѻý>T1D Patient Achieves Full Insulin Independence After Stem Cell Transplantѻý> But clinical trial currently under FDA hold as dosing is discussed Jun 06, 2022
<ѻý>Tirzepatide Reduced Albuminuria in T2D Patients With Heart Riskѻý> Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
<ѻý>Is Diabetes a Risk Factor for Long COVID? Possibly.ѻý> Mixed results in seven-study scoping review Jun 05, 2022
<ѻý>Dulaglutide Improves HbA1c for Youth With Type 2 Diabetesѻý> Safety profile consistent with that reported in adults Jun 05, 2022
<ѻý>Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesityѻý> SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
<ѻý>Bariatric Surgery Cuts Cancer Incidence, Death Riskѻý> Study looked at people with obesity who underwent two most popular procedures Jun 03, 2022
<ѻý>CDC Study: Income-Related Inequalities Widening in Diabetesѻý> Disparities differed by sex and age group Jul 01, 2021
<ѻý>ADA 2021 Roundup: SoliMix Trial; Byetta for Teens; Driving in Hypoglycemiaѻý> Noteworthy research from the American Diabetes Association virtual meeting Jun 30, 2021
<ѻý>Genetics, Socioeconomic Factors Each Tied to Diabetes and Obesityѻý> People with highest risk genetics more than 15 times more likely to have T2D Jun 30, 2021
<ѻý>Liraglutide and Insulin Come Out on Top for Glycemic Control in GRADE studyѻý> Head-to-head comparison could help individualize treatment Jun 29, 2021
<ѻý>COVID-19 Pandemic Upped Anxiety in Adults, Kids With Diabetesѻý> Providers should be screening patients on how COVID is affecting them, says researcher Jun 29, 2021
<ѻý>Investigational GLP-1 RA Cuts Heart, Renal Risk in Vulnerable Diabetes Patientsѻý> Exendin-4-based drug succeeded in cardiovascular outcomes trial Jun 28, 2021
<ѻý>180-Day Continuous Glucose Monitor Shows Promise in Adults With Diabetesѻý> Implantable Eversense system demonstrates accuracy in prospective study Jun 28, 2021
<ѻý>Hospitalization Rates for New-Onset Type 2 Diabetes in Kids Took Off During Pandemicѻý> "COVID-19 disrupted our lives in more ways than we realize" Jun 26, 2021
<ѻý>Combo GIP/GLP-1 Drug Superior for HbA1c Reduction in T2Dѻý> 40-week trial compared tirzepatide head-to-head with injectable semaglutide Jun 25, 2021
<ѻý>Ertugliflozin Tx: Safe for the Heart in Patients With T2Dѻý> Phase III VERTIS-CV trial meets primary endpoint of MACE non-inferiority Jun 17, 2020
<ѻý>No Added CV Risk for Oral Semaglutide in T2Dѻý> Safety study buffs resume for oral GLP-1 receptor agonist Jun 11, 2019
<ѻý>Urine Marker Predicts Kidney Benefit With Trulicityѻý> Secondary AWARD-7 analysis finds subgroup getting the most renal protection Jun 11, 2019
<ѻý>Dapagliflozin Boosts Renal Function in T2Dѻý> Secondary outcomes build on previously reported cardiovascular benefit from SGLT2 inhibitors Jun 10, 2019
<ѻý>Another GLP-1 Agent Cuts Heart Risk in T2Dѻý> Dulaglutide added to the growing list of diabetes treatments to show added benefit Jun 10, 2019
<ѻý>Novel Anti-CD3 Antibody Delays Progression to T1Dѻý> Single course of teplizumab slowed march to clinical type 1 diabetes in high-risk people Jun 09, 2019
<ѻý>Expert Panel Defines CGM Time-in-Range Targetsѻý> Seventy percent of readings should stay between 70-180 mg/dL, according to recommendations Jun 09, 2019
<ѻý>Vitamin D Flops for Diabetes Preventionѻý> Highly anticipated trial finds no significant difference compared to placebo after nearly three years follow-up Jun 07, 2019
<ѻý>SGLT-2 Inhibitors Tied to Lower All-Cause Mortality Riskѻý> Head-to-head comparison with DPP-4 inhibitors also showed heart protection Jun 26, 2018
<ѻý>'Artificial Pancreas' System Boosts In-Hospital T2D Controlѻý> Less time out of range, no increase in insulin or lows with fully-automated system Jun 25, 2018
<ѻý>Early T2D Treatment in Youth Disappointsѻý> Metformin, insulin didn't stop deterioration of beta-cells in adolescents with impaired glucose Jun 25, 2018
<ѻý>TB Vaccine for T1D Study Stirs Controversyѻý> Long-term data suggest BCG vaccine may alter immune attack Jun 25, 2018
<ѻý>Intensive Treatment Doesn't Cost Moreѻý> Therapy aimed at treating all organ targets extends life Jun 25, 2018
<ѻý>Farxiga Lowers HbA1c in Type 1 Diabetesѻý> Weight loss also accompanied better glycemic control Jun 25, 2018
<ѻý>Eversense CGM Comes Out on Top for Accuracy in T1Dѻý> Dexcom G5 performed best in hypoglycemia Jun 25, 2018